Adenocarcinoma of the Esophagus Completed Phase 2 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0030040 (Adenocarcinoma of the Esophagus)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01212822Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach CancerTreatment